<SEC-DOCUMENT>0001104659-22-037306.txt : 20220324
<SEC-HEADER>0001104659-22-037306.hdr.sgml : 20220324
<ACCEPTANCE-DATETIME>20220324085422
ACCESSION NUMBER:		0001104659-22-037306
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220324
FILED AS OF DATE:		20220324
DATE AS OF CHANGE:		20220324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CELESTICA INC
		CENTRAL INDEX KEY:			0001030894
		STANDARD INDUSTRIAL CLASSIFICATION:	PRINTED CIRCUIT BOARDS [3672]
		IRS NUMBER:				980185558
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14832
		FILM NUMBER:		22764822

	BUSINESS ADDRESS:	
		STREET 1:		5140 YONGE STREET, SUITE 1900
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M2N 6L7
		BUSINESS PHONE:		416-448-5800

	MAIL ADDRESS:	
		STREET 1:		5140 YONGE STREET, SUITE 1900
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M2N 6L7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2210283d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Rule&nbsp;13a-16 or 15d-16</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>under the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of March, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>001-14832</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Commission File Number)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CELESTICA INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5140 Yonge Street, Suite 1900</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Toronto, Ontario</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Canada M2N 6L7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(416) 448-5800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant files
or will file annual reports under cover of Form&nbsp;20-F or Form&nbsp;40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Form&nbsp;20-F&nbsp; <FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></FONT></TD>
    <TD STYLE="vertical-align: top; width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Form&nbsp;40-F&nbsp; <FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is
submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1): <FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is
submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7): <FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Furnished Herewith (and incorporated by reference
herein)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 90%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm2210283d1_ex99-1.htm"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="tm2210283d1_ex99-1.htm"><FONT STYLE="font-size: 10pt">Press Release, dated March 24, 2022</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information contained in Exhibit&nbsp;99.1 of this Form&nbsp;6-K
is not incorporated by reference into any registration statement (or into any prospectus that forms a part thereof) filed by Celestica
Inc. with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Date: March 24, 2022</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CELESTICA INC.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Robert Ellis&#9;&#9;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Robert Ellis</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Legal Officer and Corporate Secretary</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT&nbsp;INDEX</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 90%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm2210283d1_ex99-1.htm"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="tm2210283d1_ex99-1.htm"><FONT STYLE="font-size: 10pt">Press Release, dated March 24, 2022</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2210283d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2210283d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>FOR IMMEDIATE RELEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(All amounts in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Per share information based on diluted</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">shares outstanding unless otherwise noted.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0; text-indent: 396.75pt"><B>March&nbsp;24, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CELESTICA TO HOLD PREVIOUSLY-ANNOUNCED VIRTUAL
INVESTOR MEETING TODAY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TORONTO, Canada &ndash; Celestica Inc. (NYSE:
CLS) (TSX: CLS), a leader in design, manufacturing and supply chain solutions for the world's most innovative companies, will host a
previously-announced virtual investor meeting today from 2:00 pm to 3:30 pm EDT. During the meeting, Celestica&rsquo;s management will
discuss their multi-year transformation and highlight their strategies for continued growth. Additionally, management will provide an
in-depth discussion regarding the Hardware Platform Solutions business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Celestica will discuss historical results, as
well as financial projections, objectives and targets, including the following*:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #222222"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Anticipated
                                            2022 revenue of $6.3+ billion</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Anticipated
                                            2022 non-IFRS Lifecycle Solutions revenue** growth of at least 10%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Anticipated
                                            2022 non-IFRS operating margin** of between 4% and 5%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Targeting
                                            2022 non-IFRS free cash flow** of at least $100 million</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Targeting
                                            2022 non-IFRS adjusted earnings per share (EPS)** of between $1.55 - $1.75</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Annual
                                            non-IFRS adjusted EPS** growth objective through 2025 of 10%+</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Annual
                                            non-IFRS Lifecycle Solutions revenue** growth objective through 2025 of 10%+</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Long
                                            term-non-IFRS operating margin** objective of above 4%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Targeting
                                            2025 non-IFRS adjusted EPS** of $2.00+</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To participate in the conference call in listen-only
mode, please dial (conference ID &ndash; 9060024)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Toll-Free Dial-In Number: (888) 440-2145</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Toll Dial-In Number: (438) 803-0540</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To ensure your participation, please call in
approximately ten minutes prior to the scheduled start of the call. Analysts will have the opportunity for a Q&amp;A with speakers following
the formal remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A webcast is also available at: <U>https://onlinexperiences.com/Launch/QReg/ShowUUID=B6269195-9AC6-4B88-B931-506EA3265540</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">A recorded webcast
will be available approximately two hours after completion of the call, and will remain available for 12 months thereafter. To access
the recorded webcast visit </FONT><U>www.celestica.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* Subject in all cases to the risks set forth
in the Cautionary Note Regarding Forward-Looking Statements below, including, but not limited to, the impact of coronavirus 2019 disease
and related mutations (COVID-19) and the constrained supply chain environment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">** Non-International Financial Reporting Standards
(IFRS) financial measures (including ratios based on non-IFRS financial measures) do not have any standardized meanings prescribed by
IFRS and therefore may not be comparable to similar financial measures presented by other public companies that use IFRS or U.S. generally
accepted accounting principles (GAAP). We do not provide reconciliations for forward-looking non-IFRS financial measures, as we are unable
to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable
effort. See &ldquo;Non-IFRS Measures&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Celestica</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Celestica enables the world's best brands. Through
our recognized customer-centric approach, we partner with leading companies in Aerospace and Defense, Communications, Enterprise, HealthTech,&nbsp;Industrial,
Capital Equipment, and Energy to deliver solutions for their most complex challenges. As a leader in design, manufacturing, hardware
platform and supply chain solutions, Celestica brings global expertise and insight at every stage of product development - from the drawing
board to full-scale production and after-market services. With talented teams across North America, Europe and Asia, we imagine, develop
and deliver a better future with our customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2210283d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">For
more information, visit </FONT><U>www.celestica.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Our securities
filings can also be accessed at </FONT><U>www.sedar.com</U> and <U>www.sec.gov</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 25%; text-align: left"><B><U>Contacts:</U></B></TD><TD STYLE="text-align: justify; width: 75%"></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celestica
Global Communications</FONT> </TD><TD STYLE="text-align: justify">Celestica
Investor Relations</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"> (416) 448-2200 </TD><TD STYLE="text-align: justify">(416) 448-2211 </TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">media@celestica.com</TD><TD STYLE="text-align: justify"><U> <FONT STYLE="font-family: Times New Roman, Times, Serif">clsir@celestica.com</font></u></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B><U>Cautionary
Note Regarding Forward-looking Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>This press release
contains forward-looking statements, including, without limitation, financial projections and guidance, as well as statements related
to our targets, objectives, expectations and anticipated operating results. Such forward-looking statements may, without limitation,
be preceded by, followed by, or include words such as &ldquo;believes,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;estimates,&rdquo;
 &ldquo;intends,&rdquo; &ldquo;targets,&rdquo; &ldquo;plans,&rdquo; &ldquo;continues,&rdquo; &ldquo;project,&rdquo; &ldquo;potential,&rdquo;
 &ldquo;possible,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;seek,&rdquo; or similar expressions, or may employ such future or conditional
verbs as &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; or &ldquo;would,&rdquo;
or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. For those statements, we
claim the protection of the safe harbor for forward-looking statements contained in the U.S.&nbsp;Private Securities Litigation Reform
Act of 1995 and applicable Canadian securities laws.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Forward-looking statements
are provided to assist readers in understanding management&rsquo;s current expectations and plans relating to the future. Readers are
cautioned that such information may not be appropriate for other purposes. Forward-looking statements are not guarantees of future performance
and are subject to risks that could cause actual results to differ materially from those expressed or implied in such forward-looking
statements, including, among others, risks related to customer and segment concentration; price, margin pressures, and other competitive
factors and adverse market conditions affecting, and the highly competitive nature of, the electronics manufacturing services (EMS) industry
in general and our segments in particular (including the risk that anticipated market improvements do not materialize); delays in the
delivery and availability of components, services and/or materials, as well as their costs and quality; challenges of replacing revenue
from completed, lost or non-renewed programs or customer disengagements; our customers' ability to compete and succeed using our products
and services; changes in our mix of customers and/or the types of products or services we provide, including negative impacts of higher
concentrations of lower margin programs; managing changes in customer demand; rapidly evolving and changing technologies, and changes
in our customers' business or outsourcing strategies; the cyclical and volatile nature of our semiconductor business; the expansion or
consolidation of our operations; the inability to maintain adequate utilization of our workforce; defects or deficiencies in our products,
services or designs; volatility in the commercial aerospace industry; integrating and achieving the anticipated benefits from acquisitions
(including our acquisition of PCI Private Limited (PCI)) and &quot;operate-in-place&quot; arrangements; compliance with customer-driven
policies and standards, and third-party certification requirements; challenges associated with new customers or programs, or the provision
of new services; the impact of our restructuring actions and/or productivity initiatives, including a failure to achieve anticipated
benefits; negative impacts on our business resulting from newly-increased third-party indebtedness; the incurrence of future restructuring
charges, impairment charges, other write-downs of assets or operating losses; managing our business during uncertain market, political
and economic conditions, including among others, geopolitical and other risks associated with our international operations, including
military actions, protectionism and reactive countermeasures, economic or other sanctions or trade barriers, including in relation to
the evolving Ukraine/Russia conflict; disruptions to our operations, or those of our customers, component suppliers and/or logistics
partners, including as a result of events outside of our control, including, among others: U.S. policies or legislation, U.S. and/or
global tax reform, the potential impact of significant tariffs on items imported into the U.S. and related countermeasures, and/or the
impact of (in addition to coronavirus disease 2019 and related mutations (COVID-19) other widespread illness or disease; the scope, duration
and impact of the COVID-19 pandemic, changes to our operating model; changing commodity, materials and component costs as well as labor
costs and conditions; execution and/or quality issues (including our ability to successfully resolve these challenges); non-performance
by counterparties; maintaining sufficient financial resources to fund currently anticipated financial actions and obligations and to
pursue desirable business opportunities; negative impacts on our business resulting from any significant uses of cash (including for
the acquisition of PCI), securities issuances, and/or additional increases in third-party indebtedness (including as a result of an inability
to sell desired amounts under our uncommitted accounts receivable sales program); operational impacts that may affect PCI&rsquo;s ability
to achieve anticipated financial results; foreign currency volatility; our global operations and supply chain; competitive bid selection
processes; customer relationships with emerging companies; recruiting or retaining skilled talent; our dependence on industries affected
by rapid technological change; our ability to adequately protect intellectual property and confidential information; increasing taxes,
tax audits, and challenges of defending our tax positions; obtaining, renewing or meeting the conditions of tax incentives and credits;
the management of our information technology systems, and the fact that while we have not been materially impacted by computer viruses,
malware, ransomware, hacking attempts or outages , we have been (and may continue to be) the target of such events; the inability to
prevent or detect all errors or fraud; the variability of revenue and operating results; unanticipated disruptions to our cash flows;
compliance with applicable laws and regulations; our pension and other benefit plan obligations; changes in accounting judgments, estimates
and assumptions; our ability to maintain compliance with applicable credit facility covenants; interest rate fluctuations and the discontinuation
of LIBOR; our ability to refinance our indebtedness from time to time; deterioration in financial markets or the macro-economic environment;
our credit rating; the interest of our controlling shareholder; current or future litigation, governmental actions, and/or changes in
legislation or accounting standards; negative publicity; that we will not be permitted to, or do not, repurchase subordinate voting shares
(SVS) under any normal course issuer bid (NCIB); the impact of climate change; and our ability to achieve our environmental, social and
governance (ESG) initiative goals, including with respect to diversity and inclusion and climate change. The foregoing and other material
risks and uncertainties are discussed in our public filings at <U>www.sedar.com</U> and <U>www.sec.gov</U>, including in our most recent
MD&amp;A, our most recent Annual Report on Form&nbsp;20-F filed with, and subsequent reports on Form&nbsp;6-K furnished to, the U.S.
Securities and Exchange Commission, and as applicable, the Canadian Securities Administrators.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2210283d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>The forward-looking
statements contained in this press release are based on various assumptions, many of which involve factors that are beyond our control.
Our material assumptions include continued growth (and recovery from adverse impacts due to COVID-19) in the broader economy, supporting
the expected growth outlook in Celestica&rsquo;s end markets; continued growth in the trend of manufacturing outsourcing from customers
in diversified end markets, supporting the expected long-term growth of Celestica&rsquo;s Advanced Technology Solutions (ATS) segment;
no further material impact (other than that which is already anticipated) on revenues and costs as a result of COVID-19 related issues,
including but not limited to, measures from governments to curb the spread of the virus and potential mutations, negative impacts on
global supply chains, and no significant negative impacts to Celestica&rsquo;s operations which would adversely affect revenues, gross
margins or non-IFRS operating margin; normal customer retention rates and the impact of expected new program wins, transfers, losses
or disengagements; no unforeseen changes in our mix of customers and/or the types of products or services we provide; no unforeseen adverse
impacts from the potential impact of the pace of technological changes, customer outsourcing, program transfers, and the global economic
environment; no undue negative impact on our customers' ability to compete and succeed using our products and services from unforeseen
developments in the broader economy, or in those customers&rsquo; industries; no unforeseen material price, margin pressures, or other
competitive factors or adverse market conditions affecting the EMS industry in general or our segments in particular<FONT>,
as well as </FONT>those related to the following: <FONT>scope and duration of materials constraints and
the COVID-19 pandemic, and their impact on our sites, customers and our suppliers; </FONT>fluctuation of production schedules from our
customers in terms of volume and mix of products or services; the timing and execution of, and investments associated with, ramping new
business; the success of our customers&rsquo; products; our ability to retain programs and customers; the stability of general economic
and market conditions<FONT>, and </FONT>currency exchange rates; supplier performance <FONT>and
quality</FONT>, pricing and terms; compliance by third parties with their contractual obligations; the costs and availability of components,
materials, services, equipment, labor, energy and transportation; that our customers will retain liability for<FONT>/component
</FONT>tariffs and countermeasures; global tax legislation changes; our ability to keep pace with rapidly changing technological developments;
the timing, execution and effect of restructuring actions; the successful resolution of quality issues that arise from time to time;
the components of our leverage ratio (as defined in our credit facility); our ability to successfully diversify our customer base and
develop new capabilities; the <FONT>availability</FONT> of <FONT>resources
for, and the permissibility under our credit facility of, repurchases of outstanding SVS under NCIBs, and compliance with applicable
laws and regulations pertaining to NCIBs; compliance with applicable credit facility covenants</FONT>; anticipated demand strength in
certain of our businesses; anticipated demand weakness in, and/or the impact of anticipated adverse market conditions on, certain of
our businesses<FONT>; and that: anticipated financial results by PCI will be achieved; we are able to
successfully integrate PCI, further develop our ATS segment business, and achieve the other expected synergies and benefits from the
acquisition; all financial information provided by PCI is accurate and complete, and all forecasts of PCI&rsquo;s operating results are
reasonable and were provided to Celestica in good faith; and we will continue to have sufficient financial resources to fund currently
anticipated financial actions and obligations and to pursue desirable business opportunities</FONT>. Although management believes its
assumptions to be reasonable under the current circumstances, they may prove to be inaccurate, which could cause actual results to differ
materially (and adversely) from those that would have been achieved had such assumptions been accurate. Forward-looking statements speak
only as of the date on which they are made, and we disclaim any intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by applicable law<FONT>.</FONT></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2210283d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>All forward-looking
statements attributable to us are expressly qualified by these cautionary statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Non-IFRS Financial Measures</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The non-IFRS financial measures included in this
press release are: non-IFRS operating margin, non-IFRS free cash flow, non-IFRS adjusted EPS, and non-IFRS Lifecycle Solutions revenue
(each as defined below). These non-IFRS measures do not have any standardized meanings prescribed by IFRS and may not be comparable to
similar measures presented by other public companies that use IFRS, or who report under U.S. GAAP and use non-GAAP measures to describe
similar operating metrics. Non-IFRS financial measures are not measures of performance under IFRS and should not be considered in isolation
or as a substitute for any IFRS financial measure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management uses these measures to assess operating
performance and the effective use and allocation of resources; to provide more meaningful period-to-period comparisons of operating results;
and to enhance investors&rsquo; understanding of the core operating results of Celestica&rsquo;s business. We believe investors use both
IFRS and non-IFRS measures to assess management's past, current and future decisions associated with our priorities and our allocation
of capital, as well as to analyze how our business operates in, or responds to, swings in economic cycles or to other events that impact
our core operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not provide reconciliations for forward-looking
non-IFRS financial measures, as we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and
the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing or amount
of various events that have not yet occurred, are out of our control and/or cannot be reasonably predicted, and that would impact the
most directly comparable forward-looking IFRS financial measure. For these same reasons, we are unable to address the probable significance
of the unavailable information. Forward-looking non-IFRS financial measures may vary materially from the corresponding IFRS financial
measures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Definitions</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifecycle Solutions revenue is defined as the
aggregate revenues of our ATS segment and our Hardware Platform Solutions business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-IFRS operating margin is defined as non-IFRS
operating earnings divided by revenue. Non-IFRS operating earnings is a non-IFRS financial measure and is defined as earnings (loss)
before income taxes, Finance Costs (defined below), employee stock-based compensation expense, amortization of intangible assets (excluding
computer software) and Other Charges (recoveries) (defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-IFRS free cash flow is defined as cash provided
by (used in) operations after the purchase of property, plant and equipment (net of proceeds from the sale of certain surplus equipment
and property), lease payments and Finance Costs paid (excluding any debt issuance costs and when applicable, waiver fees related to our
credit facility). We do not consider debt issuance costs or such waiver fees (when applicable) to be part of our ongoing financing expenses.
As a result, these costs are excluded from total Finance Costs paid in our determination of non-IFRS free cash flow. Note, however, that
non-IFRS free cash flow does not represent residual cash flow available to Celestica for discretionary expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-IFRS adjusted EPS is determined by dividing
non-IFRS adjusted net earnings by the number of diluted weighted average shares outstanding. Non-IFRS adjusted net earnings is a non-IFRS
financial measure and is defined as IFRS net earnings (loss) before employee stock-based compensation expense, amortization of intangible
assets (excluding computer software), Other Charges (recoveries), and adjustments for taxes (representing the tax effects of our non-IFRS
adjustments and non-core tax impacts (tax adjustments related to acquisitions, and certain other tax costs or recoveries related to restructuring
actions or restructured sites)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finance Costs consist of interest expense and
fees related to our credit facility (including debt issuance and related amortization costs), our interest rate swap agreements, our
accounts receivable sales program and customer supplier financing programs, and interest expense on our lease obligations, net of interest
income earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2210283d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Charges (recoveries) consist of restructuring
charges, net of recoveries, transition costs (costs related to, when applicable: the relocation of our Toronto manufacturing operations
and the move of our corporate headquarters into and out of a temporary location; and manufacturing line transfers from closed sites);
net impairment charges; Acquisition Costs (as defined below); legal settlements (recoveries); and specified credit facility-related charges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acquisition Costs consist of acquisition-related
consulting, transaction and integration costs, and charges or releases related to the remeasurement of indemnification assets or the
release of indemnification or other liabilities recorded in connection with acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2210283d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2210283d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !' *@# 2(  A$! Q$!_\0
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M=X&,<\]^.ZKFI]?U2^OK.'3=*E^QRO/#<WEQB,VS*,(P0\N"?3TH \+M]/\
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MMI&_V'R  FYF ?S.ISM88[5K30QW$3Q2HLD;C:R,,@CT(HHH ?1110 4444
;%%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
